GnRHa 6月剂型在真实世界中治疗CPP的病历数据表明，6月剂型与1月剂型疗效和安全性相当，GnRHa 6月剂型是一种可替代1月剂型的便捷治疗方案。

• When comparing long versus short gonadotropin-releasing hormone agonists (GnRHa) treatment, there was little to no difference between groups for live birth and ongoing pregnancy rates, but the long ...

The research centers around gonadotropin-releasing hormone agonists (GnRHa), drugs that suppress the production of estrogen and progesterone in the ovaries and testosterone in the testicles.